| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |